Kingsview Wealth Management, LLC Bristol Myers Squibb CO Transaction History

Kingsview Wealth Management, LLC

$3.97 Billion
Q2 2024

A detailed history of Kingsview Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Kingsview Wealth Management, LLC holds 32,751 shares of BMY stock, worth $1.69 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

32,751

Previous 175,679 81.36%

Holding current value

$1.69 Million

Previous $9.53 Million 85.72%

% of portfolio

0.03%

Previous 0.25%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $5.75 Million - $7.57 Million	-142,928 Reduced 81.36%	32,751 $1.36 Million
Q1 2024 May 09, 2024	BUY	$47.98 - $54.4 $447,029 - $506,844	9,317 Added 5.6%	175,679 $9.53 Million
Q4 2023 Feb 08, 2024	BUY	$48.48 - $57.85 $4.9 Million - $5.84 Million	101,010 Added 154.56%	166,362 $8.54 Million
Q3 2023 Nov 07, 2023	BUY	$57.89 - $64.73 $510,010 - $570,271	8,810 Added 15.58%	65,352 $3.79 Million
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $86,072 - $95,569	1,351 Added 2.45%	56,542 $3.62 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $597,895 - $678,148	-9,099 Reduced 14.15%	55,191 $3.83 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $187,977 - $222,592	2,745 Added 4.46%	64,290 $4.63 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $764 - $451,742	-5,879 Reduced 8.72%	61,545 $4.38 Million
Q2 2022 Aug 16, 2022	BUY	$72.62 - $79.98 $1.17 Million - $1.29 Million	16,118 Added 31.42%	67,424 $5.19 Million
Q1 2022 Feb 08, 2024	SELL	$61.48 - $73.72 $7.04 Million - $8.44 Million	-114,510 Reduced 68.83%	51,852 $3.79 Million
Q4 2021 Feb 17, 2022	BUY	$53.63 - $62.52 $116,377 - $135,668	2,170 Added 4.42%	51,306 $3.2 Million
Q3 2021 Dec 03, 2021	BUY	$59.17 - $69.31 $242,123 - $283,616	4,092 Added 9.08%	49,136 $2.91 Million
Q2 2021 Aug 17, 2021	SELL	$61.91 - $67.42 $83,392 - $90,814	-1,347 Reduced 2.9%	45,044 $3 Million
Q1 2021 May 24, 2021	SELL	$59.34 - $66.74 $1.09 Million - $1.22 Million	-18,286 Reduced 28.27%	46,391 $2.92 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $87,418 - $99,061	1,514 Added 2.4%	64,677 $4.01 Million
Q3 2020 Nov 19, 2020	BUY	$57.43 - $63.64 $52,318 - $57,976	911 Added 1.46%	63,163 $3.81 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $1.22 Million - $1.42 Million	22,186 Added 55.37%	62,252 $3.66 Million
Q1 2020 May 11, 2020	BUY	$46.4 - $67.43 $516,988 - $751,305	11,142 Added 38.52%	40,066 $2.23 Million
Q4 2019 Jan 31, 2020	BUY	$49.21 - $64.19 $1.2 Million - $1.57 Million	24,417 Added 541.76%	28,924 $1.86 Million
Q4 2019 Jan 30, 2020	SELL	$49.21 - $64.19 $213,620 - $278,648	-4,341 Reduced 49.06%	4,507 $276,000
Q3 2019 Jan 29, 2020	BUY	$42.77 - $50.71 $23,737 - $28,144	555 Added 6.69%	8,848 $449,000
Q2 2019 Jan 29, 2020	BUY	$44.62 - $49.34 $54,481 - $60,244	1,221 Added 17.27%	8,293 $376,000
Q1 2019 Jan 29, 2020	BUY	$45.12 - $53.8 $58,836 - $70,155	1,304 Added 22.61%	7,072 $337,000
Q4 2018 Jan 29, 2020	SELL	$48.76 - $63.23 $13,604 - $17,641	-279 Reduced 4.61%	5,768 $300,000
Q3 2018 Jan 29, 2020	BUY	$55.19 - $62.25 $81,129 - $91,507	1,470 Added 32.12%	6,047 $375,000
Q2 2018 Jan 29, 2020	BUY	$50.53 - $62.98 $3,537 - $4,408	70 Added 1.55%	4,577 $253,000
Q4 2017 Jan 29, 2020	SELL	$59.94 - $65.35 $1,558 - $1,699	-26 Reduced 0.57%	4,507 $276,000
Q3 2017 Jan 29, 2020	BUY	$55.23 - $63.74 $62,575 - $72,217	1,133 Added 33.32%	4,533 $289,000
Q2 2017 Jan 29, 2020	SELL	N/A	-580 Reduced 14.57%	3,400 $189,000
Q1 2017 Jan 29, 2020	BUY	N/A	3,980	3,980 $216,000

Others Institutions Holding BMY

# of Institutions

2,402

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $110B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsview Wealth Management, LLC with notifications on news.

Account

Kingsview Wealth Management, LLC Bristol Myers Squibb CO Transaction History